Oliver Bohnsack

Background

About Oliver Bohnsack

In January 2021 the former Parexel Informatics business unit separated and had been rebranded as Calyx.ai. Now through the merger with former Invicro we are Perceptive. Again. YES! Vice President Scientific and Medical Affairs Medical Imaging in Berlin, Germany. Head of Oncology. Bio: As Global Head of Oncology his office is in Berlin Germany and as a Board certified Radiologist he has training and background in both Germany and the U.S.A. Throughout his career with Calyx since now 20+ years he medically and scientifically led and managed the imaging components of more than 600 clinical trials. He has developed equally as many imaging charters for various indications and complexities and thus far supported with his contributions the approval of 25+ oncology medications. Dr. Bohnsack regularly presents at international conferences and publishes on Imaging in Clinical Trials, especially regarding the use of standardized review criteria and imaging based endpoints with a more recent focus on immune-oncology. He is co-author of the immune-related response criteria (irRC, 2009) and first author of irRECIST (2014), co-author of Comparison of Assessments using RECIST 1.1 and irRECIST by Manitz J, Eggleton P. et al.(JITC 2022). His Masters in Business Administration in Health Care Management is from the University of California, Irvine and his Ph.D. in Radiology in Computer Tomography Radiation Modulation and Reduction is from the University of Munich.